154 results on '"Qayyum, Aliya"'
Search Results
2. Magnetic Resonance Elastography (MRE) to Assess Hepatic Fibrosis
3. Serologic, radiographic, and tissue-based markers associated with major pathologic response after treatment with neoadjuvant immunotherapy in patients with resectable hepatocellular carcinoma.
4. Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients
5. Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial
6. Effect of bead size and doxorubicin loading on tumor cellular injury after transarterial embolization and chemoembolization in a rat model of hepatocellular carcinoma
7. 42 The role of tissue stiffness in predicting the immunotherapy response in hepatocellular carcinoma
8. Diffuse Liver Disease
9. Contributors
10. Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib
11. Novel deep learning-based noise reduction technique for prostate magnetic resonance imaging
12. CONTRIBUTORS
13. THE ROLE OF MAGNETIC RESONANCE IMAGING IN THE EVALUATION OF GYNECOLOGIC DISEASE
14. Effect of sarcopenia on systemic targeted therapy response in patients with advanced hepatocellular carcinoma
15. Prognostic Significance of Serum Insulin-Like Growth Factor-1 in Hepatocellular Cancer Patients: A Validation Study
16. The role of ALBI and IGF-CTP score in refining prognostication of HCC.
17. Treatment outcome and prognostic indicators in 26 cases of fibrolamellar hepatocellular carcinoma under interferon based therapy.
18. Feasibility of Automated Volumetric Assessment of Large Hepatocellular Carcinomas' Responses to Transarterial Chemoembolization
19. Randomized, open-label, perioperative phase II study evaluating nivolumab alone or nivolumab plus ipilimumab in patients with resectable HCC.
20. Immune checkpoint blockade (ICB) response evaluation with MRI/MR elastography (MRE) in surgical and nonsurgical patients with HCC.
21. IGF-1 Child-Turcotte-Pugh score as a predictor of overall survival to therapy in CTP-A, BCLC stage C patients with advanced hepatocellular carcinoma.
22. Immunotherapy response evaluation with magnetic resonance elastography (MRE) in advanced HCC
23. Hepatic Arterial Bland Embolization Increases Th17 Cell Infiltration in a Syngeneic Rat Model of Hepatocellular Carcinoma
24. Molecular profiling by circulating tumor DNA (ctDNA) and benefit from anti-PD-1 in HCC.
25. Clinical and prognostic significance of serum levels of fatty acid binding proteins in hepatocellular carcinoma (HCC).
26. Immunotherapy response evaluation with MR elastography (MRE) in advanced HCC.
27. Automated Volumetric Assessment of Hepatocellular Carcinoma Response to Sorafenib
28. Interobserver agreement in distinguishing large adrenal adenomas and adrenocortical carcinomas on computed tomography
29. Baseline Apparent Diffusion Coefficient as a Predictor of Response to Liver-Directed Therapies in Hepatocellular Carcinoma
30. ACR Appropriateness Criteria® Staging of Pancreatic Ductal Adenocarcinoma
31. ACR Appropriateness Criteria ® Chronic Liver Disease
32. ACR Appropriateness Criteria ® Chronic Liver Disease
33. ACR Appropriateness Criteria® Suspected Liver Metastases
34. Cancer Genomics and Important Oncologic Mutations: A Contemporary Guide for Body Imagers
35. Evaluation of Abdominal Computed Tomography Image Quality Using a New Version of Vendor-Specific Model-Based Iterative Reconstruction
36. Ovarian Cancer, the Revised FIGO Staging System, and the Role of Imaging
37. Dual-energy CT of pancreatic adenocarcinoma: reproducibility of primary tumor measurements and assessment of tumor conspicuity and margin sharpness
38. Current update on primary pancreatic lymphoma
39. Patients Prefer Results From the Ordering Provider and Access to Their Radiology Reports
40. An Update of Clinical CT Imaging of Pancreatic Neoplasm: Tips, Tricks, and Pitfalls
41. An Update of Practical CT Adrenal Imaging: What Physicians Need to Know
42. Multidetector CT detection of peritoneal metastases: evaluation of sensitivity between standard 2.5 mm axial imaging and maximum-intensity-projection (MIP) reconstructions
43. CT Liver Imaging: What is New?
44. CAIPIRINHA-VIBE and GRAPPA-VIBE for Liver MRI at 1.5 T
45. ACR Appropriateness Criteria® Acute Pancreatitis
46. Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer
47. Can Hospital-Based Cellular Phones Improve On-Call Communication?
48. MR Imaging of Diffuse Liver Disease
49. ACR Appropriateness Criteria Right Upper Quadrant Pain
50. P4 radiology of hepatobiliary diseases with gadoxetic acid-enhanced MRI as a biomarker
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.